Zephrex-D Efficacy Claim Passes NAD Review After Nexafed Firm Objects

NAD says that Westport Pharmaceuticals supported claims for Zephrex-D’s rate of relief and efficacy challenged by Acura Pharmaceuticals, manufacturer of Nexafed, another nonprescription PSE drug formulated to prevent extraction of the ingredient.

More from United States

More from North America